A Call for the Digital/Social Expert [Consultant] as a Priority Partner

With nearly a decade working in the rapidly evolving industry, I’ve noticed a variety of reasons why the pitch process, relationships between digital/social experts, account teams at agencies and properly following through on execution are not working smoothly. This is one of the core reasons behind Pharma’s lack of progress – not to minimize regulatory hurdles at all – but we also need to recognize that traditional PR, advertising, marketing processes and people are being deployed into what is a very complex, dynamic environment. Continue reading A Call for the Digital/Social Expert [Consultant] as a Priority Partner

Mobile Apps & Search to Enhance Doctor-Patient Discussions

Search and the fact that a mobile device may already be in a physician’s hand during a patient visit offers a unique opportunity – let’s use that device to better communicate information about a disease or condition to the patient in a way they are more likely to understand. Technology allows touch interaction, video provides a visual means of understanding. Memorability even comes merely in the form of awe in how cool an app may be, leading one to explore others like it.Continue reading Mobile Apps & Search to Enhance Doctor-Patient Discussions

Community Managers: Striking a Balance Between Passion and Experience

The most successful community managers will be passionate about their work, which means the content they’re sharing will be higher quality and the conversations they are having more relevant. Personality, enthusiasm and expertise in the topics shows true commitment, which entices engagement and builds trust within the community – especially as it relates to health.  Community Managers – theContinue reading Community Managers: Striking a Balance Between Passion and Experience

Explained: New FDA Guidance on Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media

Translation: What aspects of social media is pharma responsible for and the process for interacting in real-time while adhering to FDA postmarketing submission guidelines. On the path to releasing full guidance for pharma promotional activities in social media in July 2014, yesterday, the Food and Drug Administration (FDA) released draft guidance for comment, specific toContinue reading Explained: New FDA Guidance on Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media